Abstract submission
DEADLINE FOR ABSTRACT SUBMISSION: June 3rd, 2024
One single abstract per presenting author can be submitted; however, submitters can be co-authors on several abstract.
Style and instructions*
File format
Word (.doc, .docx)
Language
English
Font
Times New Roman, 11-point font
Title
Boldface, lowercase letters
Authors Names
For each author, type in: last name, first name and indexes of the affiliations separated by a comma. (Eg: Rossi Mario 1,2,3)
List of author institutions:
Italics
Abstract body
Less than 300 words, single space
Please note: it is mandatory including, after the abstract body:
- Name of the presenting author
- E-mail and phone number of the presenting author
- Current status of the presenting author (undergraduate/graduate student,PhD student, Postdoctoral fellow, Assistant/Associate/Full professor, Nonacademic researcher, other)**
- SELECTED TOPIC
* Abstracts
which do not follow instructions will be rejected
**Abstracts
which do not contain that information will be rejected
Final selection
Abstracts will be evaluated by a Scientific Committee and notification on their acceptance will be sent to the presenting author tentatively by July 5th, 2024.
Abstracts will be considered in one of the following areas:
- CNS primary tumours
- Brain metastasis
- Brain cancer/metastasis remodelling of brain circuits and functions
- Cancer-neuron synapses
- Neural stem cells and cancer
- Glial cells in cancer
- Neurogenesis and axonogenesis in cancer
- Neuronal transdifferentiation of cancer cells
- Neuroimmune axis in cancer and cancer microenvironment
- BBB and cancer
- Meninges and cancer
- Perineural invasion in peripheral tumours
- Cancer and pain
- Cancer-associated cachexia
- Cancer-induced epilepsy
- Sleep disruption and cancer
- Circadian rhythms and cancer
- Metabolic and immunologic disruptions in cancer
- Cognitive effects of cancer and cancer treatments
- Cancer/cancer therapy and mood disorders
- CART cell therapy in primary brain tumors
- Neuronal /neural mechanisms in chemoresistance of cancer cells
- Drug repurposing based on brain/neurons-tumour interactions
- Neurodevelopment disorders and cancer susceptibility
- Neuromuscular disorders and cancer
- Neurodegenerative disorders and cancer